Landing - Corporate Profile Text
HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
More events are coming soon.
March 15, 2023HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
March 13, 2023HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
March 8, 2023HOOKIPA Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 15, 2023